Bernie Sanders urged Denmark to pressure its most useful firm, Novo Nordisk A/S, to decrease its drug costs, in a letter submitted by the US senator to one of many Nordic nation’s largest newspapers.
Sanders, who chairs the Senate’s Well being, Training, Labor and Pensions Committee, referred to as on Danes to stress Novo to “significantly reduce the outrageously high prices for Ozempic and Wegovy in the US and other parts of the world,” in keeping with the letter, revealed by the Politiken newspaper on Monday.
Sanders has additionally referred to as on Novo on to decrease its costs and has requested the drugmaker to answer to a sequence of questions on prices and manufacturing. The corporate is presently unable to supply sufficient of its Wegovy weight-loss therapy to satisfy demand, and persons are additionally hording diabetes drug Ozempic, which incorporates the identical energetic ingredient.
Sanders, who wrote within the Monday letter that he admires Denmark’s welfare system, stated Novo prices roughly ten occasions extra for Ozempic within the US in contrast with European international locations. “Help the American people do something about the obesity and diabetes epidemic we are facing,” the senator stated.
